Drugs / BMS-986484
last change Oct 2024 re-read 2 minutes ago

BMS-986484

Developed for
cancer
Investigated by
Bristol-Myers Squibb

Trials 1 · a red edge is where a trial was stopped

202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06544655 Oct 2024 → Oct 2027 expected cancer Bristol-Myers Squibb Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BMS-986484 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06544655